Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Use of Atropine 0.01% in the Prevention and Control of Myopia (ATOM3)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03140358
Recruitment Status : Recruiting
First Posted : May 4, 2017
Last Update Posted : October 26, 2017
Sponsor:
Collaborator:
National Medical Research Council (NMRC), Singapore
Information provided by (Responsible Party):
Audrey Chia Wei-Lin, Singapore National Eye Centre

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : May 2, 2021
Estimated Study Completion Date : May 2, 2023